{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:29:31Z","timestamp":1788715771269,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sustainable Chemistry and Pharmacy"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.scp.2022.100744","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T03:00:55Z","timestamp":1655175655000},"page":"100744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Eco-friendly stability-indicating HPTLC micro-determination of the first FDA approved SARS-CoV-2 antiviral prodrug Remdesivir: Study of degradation kinetics and structural elucidation of the degradants using HPTLC-MS"],"prefix":"10.1016","volume":"29","author":[{"given":"Amira H.","family":"Abo-Gharam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina S.","family":"El-Kafrawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.scp.2022.100744_bib2","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1515\/cclm-2020-0612","article-title":"Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient","volume":"58","author":"Alvarez","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.scp.2022.100744_bib3","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1093\/jac\/dkaa152","article-title":"Development and validation of a UHPLC-MS\/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2\/COVID-19 and Ebola virus disease","volume":"75","author":"Avataneo","year":"2020","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.scp.2022.100744_bib4","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/16583655.2021.1991737","article-title":"A comparative study of HPLC and UV spectrophotometric methods for remdesivir quantification in pharmaceutical formulations","volume":"15","author":"Bulduk","year":"2021","journal-title":"J. TAIBAH UNIV. SCI."},{"key":"10.1016\/j.scp.2022.100744_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.scp.2022.100744_bib6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1021\/acscentsci.0c00489","article-title":"Remdesivir: a review of its discovery and development leading to emergency use authorization for treatment of COVID-19","volume":"6","author":"Eastman","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.scp.2022.100744_bib7","article-title":"Green chromatographic methods for simultaneous micro-determination of empagliflozin, linagliptin with metformin and its pharmacopoeial impurities in pure form and triple combination tablets: a comparative study","volume":"25","author":"El-Kafrawy","year":"2022","journal-title":"Sustain. Chem. Pharm."},{"key":"10.1016\/j.scp.2022.100744_bib8","article-title":"Comparative study of two versatile multi-analyte chromatographic methods for determination of diacerein together with four non-steroidal anti-inflammatory drugs: greenness appraisal using Analytical Eco-Scale and AGREE metrics","volume":"28","author":"El-Kafrawy","year":"2022","journal-title":"Sustain. Chem. Pharm."},{"issue":"23","key":"10.1016\/j.scp.2022.100744_bib9","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1039\/D1AY00469G","article-title":"Green and sensitive spectrofluorimetric determination of Remdesivir, an FDA approved SARS-CoV-2 candidate antiviral; application in pharmaceutical dosage forms and spiked human plasma","volume":"13","author":"Elmansi","year":"2021","journal-title":"Anal. Methods"},{"key":"10.1016\/j.scp.2022.100744_bib10","series-title":"Veklury EPAR","author":"European Medicines Agency EMA","year":"2020"},{"key":"10.1016\/j.scp.2022.100744_bib11","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","article-title":"Analytical Eco-Scale for assessing the greenness of analytical procedures","volume":"37","author":"Ga\u0142uszka","year":"2012","journal-title":"Trends Anal. Chem."},{"key":"10.1016\/j.scp.2022.100744_bib12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.trac.2013.04.010","article-title":"The 12 principles of green analytical chemistry and the SIGNIFICANCE mnemonic of green analytical practices","volume":"50","author":"Ga\u0142uszka","year":"2013","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.scp.2022.100744_bib13","doi-asserted-by":"crossref","first-page":"S2908","DOI":"10.1016\/j.arabjc.2013.11.023","article-title":"HPLC-DAD stability indicating determination of pentoxyverine citrate. Application to degradation kinetics and assay of syrup dosage form","volume":"10","author":"Gawad","year":"2017","journal-title":"Arab. J. Chem."},{"issue":"15","key":"10.1016\/j.scp.2022.100744_bib14","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1074\/jbc.AC120.013056","article-title":"The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.scp.2022.100744_bib15","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.scp.2022.100744_bib16","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1074\/jbc.RA120.013679","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","volume":"295","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.scp.2022.100744_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113935","article-title":"Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC\u2013MS\/MS method in human serum","volume":"196","author":"Habler","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"12","key":"10.1016\/j.scp.2022.100744_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.5212","article-title":"Accelerated stability study of the ester prodrug Remdesivir; recently FDA approved Covid-19 antiviral using RP-HPLC with fluorimetric and diode array detection","volume":"35","author":"Hamdy","year":"2021","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.scp.2022.100744_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.talanta.2011.11.048","article-title":"New concept for HPTLC peak purity assessment and identification of drugs in multi-component mixtures","volume":"88","author":"Hewala","year":"2012","journal-title":"Talanta"},{"key":"10.1016\/j.scp.2022.100744_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113806","article-title":"Challenges and stepwise fit-for-purpose optimization for bioanalyses of remdesivir metabolites nucleotide monophosphate and triphosphate in mouse tissues using LC\u2013MS\/MS","volume":"194","author":"Hu","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"12","key":"10.1016\/j.scp.2022.100744_bib21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3390\/separations8120243","article-title":"Green stability indicating organic solvent-free HPLC determination of Remdesivir in substances and pharmaceutical dosage forms","volume":"8","author":"Ibrahim","year":"2021","journal-title":"Separations"},{"key":"10.1016\/j.scp.2022.100744_bib22","series-title":"Note for Guidance on Stability Testing: Stability Testing of New Substances and Products Q1A(R2), International Conference on Harmonization of Technical Requirements of Pharmaceuticals for Human Use","year":"2003"},{"key":"10.1016\/j.scp.2022.100744_bib23","article-title":"Q2A(R1), validation of analytical procedures: text and methodology","year":"2005","journal-title":"Int. Conf. Harmonisation"},{"key":"10.1016\/j.scp.2022.100744_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S1473-3099(20)30438-2","article-title":"COVID-19 human challenge studies: ethical issues","volume":"20","author":"Jamrozik","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.scp.2022.100744_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2021.106917","article-title":"A novel stability-indicating HPLC-DAD method for determination of favipiravir, a potential antiviral drug for COVID-19 treatment; application to degradation kinetic studies and in-vitro dissolution profiling","volume":"172","author":"Marzouk","year":"2022","journal-title":"Microchem. J."},{"issue":"9","key":"10.1016\/j.scp.2022.100744_bib26","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/chromsci\/bmw103","article-title":"Stability-indicating HPLC-DAD method for the determination of linagliptin in tablet dosage form: application to degradation kinetics","volume":"54","author":"Mourad","year":"2016","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.scp.2022.100744_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2021.107101","article-title":"Novel environment friendly TLC-densitometric method for the determination of anti-coronavirus drugs \u201cRemdesivir and Favipiravir\u201d: green assessment with application to pharmaceutical formulations and human plasma","volume":"174","author":"Noureldeen","year":"2022","journal-title":"Microchem. J."},{"key":"10.1016\/j.scp.2022.100744_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.procbio.2020.12.014","article-title":"Rapid determination of remdesivir (SARS-CoV-2 drug) in human plasma for therapeutic drug monitoring in COVID-19-Patients","volume":"102","author":"Pasupuleti","year":"2021","journal-title":"Process Biochem."},{"key":"10.1016\/j.scp.2022.100744_bib29","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE-analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.scp.2022.100744_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the analytical procedure: green Analytical Procedure Index","volume":"181","author":"P\u0142otka-Wasylka","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.scp.2022.100744_bib31","first-page":"1","article-title":"A novel liquid chromatographic method for the quantitative determination of degradation products in Remdesivir injectable drug product","author":"Ramakrishna Reddy","year":"2021","journal-title":"J. Chromatogr. Sci."},{"issue":"396","key":"10.1016\/j.scp.2022.100744_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.scp.2022.100744_bib33","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/jaoac\/93.3.754","article-title":"Review of HPTLC in drug analysis: 1996-2009","volume":"93","author":"Sherma","year":"2010","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.scp.2022.100744_bib34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jpba.2012.03.034","article-title":"HPTLC methods to assay active ingredients in pharmaceutical formulations: a review of the method development and validation steps","volume":"66","author":"Shewiyo","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"4","key":"10.1016\/j.scp.2022.100744_bib35","first-page":"46227","article-title":"Validated stability indicating method for determination of Umifenovir- Remdesivir in presence of its degradation products","volume":"11","author":"Surabhi","year":"2021","journal-title":"Int. J. Dev. Res."},{"key":"10.1016\/j.scp.2022.100744_bib36","first-page":"9201","article-title":"Theoretical description for anti-COVID-19 drug Remdesivir electrochemical determination, assisted by squaraine Dye\u2013Ag2O2 composite","volume":"11","author":"Tkach","year":"2021","journal-title":"Biointerface. Res. Appl. Chem."},{"key":"10.1016\/j.scp.2022.100744_bib37","series-title":"FDA EUA Remdesivir Fact Sheet for Health Care Providers","year":"2020"},{"key":"10.1016\/j.scp.2022.100744_bib38","series-title":"EUA 046 (Remdesivir) FS for Parents Caregivers (01212022) (fda.gov). \"Fact Sheet for Patients and Parent\/Caregivers Emergency Use Authorization (EUA) of Remdesivir for Coronavirus Disease 2019 (COVID-19)","year":"2020"},{"key":"10.1016\/j.scp.2022.100744_bib39","series-title":"FDA Approves First Treatment for COVID-19","year":"2020"},{"key":"10.1016\/j.scp.2022.100744_bib40","series-title":"FDA's Approval of Veklury (Remdesivir) for the Treatment of COVID-19","year":"2020"},{"key":"10.1016\/j.scp.2022.100744_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature17180","article-title":"Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys","volume":"531","author":"Warren","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.scp.2022.100744_bib42","series-title":"Therapeutics and COVID-19: Living Guideline -","author":"World Health Organization WHO","year":"2022"},{"key":"10.1016\/j.scp.2022.100744_bib43","series-title":"Latest COVID-19 Information","year":"2022"},{"key":"10.1016\/j.scp.2022.100744_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2021.114118","article-title":"Validation of LC-MS\/MS methods for determination of remdesivir and its metabolites GS-441524 and GS-704277 in acidified human plasma and their application in COVID-19 related clinical studies","volume":"617","author":"Xiao","year":"2021","journal-title":"Anal. Biochem."}],"container-title":["Sustainable Chemistry and Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352554122001486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352554122001486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T01:37:56Z","timestamp":1762479476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352554122001486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":43,"alternative-id":["S2352554122001486"],"URL":"https:\/\/doi.org\/10.1016\/j.scp.2022.100744","relation":{},"ISSN":["2352-5541"],"issn-type":[{"value":"2352-5541","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eco-friendly stability-indicating HPTLC micro-determination of the first FDA approved SARS-CoV-2 antiviral prodrug Remdesivir: Study of degradation kinetics and structural elucidation of the degradants using HPTLC-MS","name":"articletitle","label":"Article Title"},{"value":"Sustainable Chemistry and Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.scp.2022.100744","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100744"}}